Effects of age and sex on the disposition of retigabine.
about
Mechanisms of Action of Antiseizure Drugs and the Ketogenic DietRetigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data.Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizuresNeuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.Clinical utility of adjunctive retigabine in partial onset seizures in adults.Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy.Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits.Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study.Efficacy of retigabine in adjunctive treatment of partial onset seizures in adults.Pharmacotherapy of epilepsy: newly approved and developmental agents.Retigabine (ezogabine): in partial-onset seizures in adults with epilepsy.Novel medications for epilepsy.Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.Retigabine for partial onset seizures.Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects.The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine.
P2860
Q28272457-6C0F4033-D0FA-4CD6-9110-9E30143BC1A3Q34333196-94A26E3E-ADD8-4551-88F4-97959BB17DEBQ34342674-7902887D-0D8A-4D2E-9C7C-06B49CFC9AC2Q35117817-230E79DB-3C13-4C8A-8823-4E917410E77CQ35683922-944E6A44-17A3-4855-9302-695C3B6DB687Q35717049-A5C112C0-7071-41D4-B05F-EED22CCCBB27Q36144410-6855FC48-C9DA-43B0-B909-9CB642F87BDCQ36692887-0CC1BC00-B66C-4EA6-BF01-6C691B120F82Q36958975-0DFBD671-D5DB-48EA-B240-732D7CF8D851Q37302567-44CB98EF-85BF-42B6-9B5E-24FE993A8B10Q37831297-53207270-EDD5-48C5-AB3C-593E0781CFDEQ37936428-AEF29DAF-C550-4E23-8D93-1D56D129C0F8Q37950518-F7880F0C-4CF2-43A1-8021-CEF9D627FF5EQ37992162-094BC7AD-1656-42CA-B828-B1F75DFD723DQ38006978-FBEFC32E-39C4-4FF0-B033-BA50978D6B01Q38044694-978EFFE1-E943-4C05-991A-E1AFA3996EF0Q38851234-ABF87652-F4B1-4BEC-A211-84DBC21C59A3Q42385228-888DA2E5-77EB-4E2B-ABC5-BDA6BAA4A2F2Q44405609-785BD4A4-1CAC-4136-825F-4CA97E8443CFQ46886423-6115F66A-A447-40D3-8A62-3A9E1DBB8E7F
P2860
Effects of age and sex on the disposition of retigabine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Effects of age and sex on the disposition of retigabine.
@en
Effects of age and sex on the disposition of retigabine.
@nl
type
label
Effects of age and sex on the disposition of retigabine.
@en
Effects of age and sex on the disposition of retigabine.
@nl
prefLabel
Effects of age and sex on the disposition of retigabine.
@en
Effects of age and sex on the disposition of retigabine.
@nl
P2093
P356
P1476
Effects of age and sex on the disposition of retigabine.
@en
P2093
Geraldine M Ferron
Hans-Peter Cnota
Jeffrey Paul
Katharina Erb
Lyette Richards
Norbert Knebel
Peter Ruus
Robert Hermann
Steven Troy
P356
10.1067/MCP.2003.12
P407
P577
2003-01-01T00:00:00Z